These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 20477810

  • 1. Comprehensive flow cytometry phenotype in acute leukemia at diagnosis and at relapse.
    Li X, Du W, Liu W, Li X, Li H, Huang SA.
    APMIS; 2010 May; 118(5):353-9. PubMed ID: 20477810
    [Abstract] [Full Text] [Related]

  • 2. The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia.
    Zelezníková T, Babusíková O.
    Neoplasma; 2006 May; 53(6):500-6. PubMed ID: 17167719
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring.
    Langebrake C, Brinkmann I, Teigler-Schlegel A, Creutzig U, Griesinger F, Puhlmann U, Reinhardt D.
    Cytometry B Clin Cytom; 2005 Jan; 63(1):1-9. PubMed ID: 15624201
    [Abstract] [Full Text] [Related]

  • 5. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 6. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
    Al-Mawali A, Gillis D, Lewis I.
    Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB, Zheng JE, Gu JX, Yao JX, Yang J, Liu J, Li XQ, He YL, Yu JM, Wei J, Liu ZP, Huang SA.
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A, Gillis D, Hissaria P, Lewis I.
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [Abstract] [Full Text] [Related]

  • 10. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
    Voskova D, Schoch C, Schnittger S, Hiddemann W, Haferlach T, Kern W.
    Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
    [Abstract] [Full Text] [Related]

  • 11. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993 Nov; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ, Pullen DJ, Winick N, Martin PL, Bowman WP, Camitta B.
    Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
    [Abstract] [Full Text] [Related]

  • 14. Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.
    Drach J, Drach D, Glassl H, Gattringer C, Huber H.
    Cytometry; 1992 Nov; 13(8):893-901. PubMed ID: 1459006
    [Abstract] [Full Text] [Related]

  • 15. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Nov; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 16. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Nov; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of cytoplasmic antigens in acute leukemia by flow cytometry].
    Kawai S, Zha Z, Yamamoto Y, Nakadate H, Kawakami K, Kikuta A, Utsumi J, Nishikawa K, Mimaya J, Miyake M.
    Rinsho Ketsueki; 1993 Jan; 34(1):13-20. PubMed ID: 8450602
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.